Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-01 @ 6:51 PM
Study NCT ID:
NCT04366232
Status:
TERMINATED
Last Update Posted:
2020-12-16
First Post:
2020-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-27
First Submit QC Date:
None
Study First Post Date:
2020-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-11
Last Update Post Date:
2020-12-16
Last Update Post Date Type:
ACTUAL